Toronto Dominion Bank Corbus Pharmaceuticals Holdings, Inc. Transaction History

Toronto Dominion Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$0.17 - $5.31 $141 - $4,417	832 Added 24.11%	4,283 $1,000
Q2 2022 Aug 11, 2022	BUY	$0.21 - $0.53 $473 - $1,194	2,254 Added 188.3%	3,451 $1,000
Q1 2022 May 09, 2022	SELL	$0.32 - $0.67 $673 - $1,409	-2,104 Reduced 63.74%	1,197 $1,000
Q4 2021 Feb 04, 2022	BUY	$0.6 - $1.11 $1,978 - $3,659	3,297 Added 82425.0%	3,301 $2,000
Q3 2021 Nov 08, 2021	BUY	$1.01 - $1.82 $4 - $7	4 New	4 $0

38.7K

Ticker CRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,268,000
Market Cap $1.22B
Description
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

Stay updated on Toronto Dominion Bank with notifications on news.